Brief: CTI BioPharma Corp Reports Q3 Loss Per Share Of $0.13
07/11/2022 23:05
Nov 7 (Reuters) - CTI BioPharma Corp CTIC.O :
* CTI BIOPHARMA REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
* CTI BIOPHARMA CORP Q3 LOSS PER SHARE $0.13
Source text for Eikon: ID:nPn7CgwYMa
Further company coverage: CTIC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CTI Biopharma
See all newsBrief: CTI Biopharma Cancels 2023 Annual Meeting Of Stockholders
U.S. RESEARCH ROUNDUP-Albemarle, Ellington Financial, Savara
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
U.S. STOCKS ON THE MOVE-First Citizens BancShares, Sarepta, Celsius Holdings
U.S. STOCKS ON THE MOVE-Taboola, US banks, Copper miners